SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-24-000025
Filing Date
2024-08-07
Accepted
2024-08-07 08:04:51
Documents
85
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnlk-20240630.htm   iXBRL 10-Q 1111344
2 EX-31.1 mltx_2024q2xex311dasilva.htm EX-31.1 10304
3 EX-31.2 mltx_2024q2xex312bodenstedt.htm EX-31.2 10216
4 EX-32.1 mltx_2024q2xex321dasilva.htm EX-32.1 4948
5 EX-32.2 mltx_2024q2xex322bodenstedt.htm EX-32.2 4885
  Complete submission text file 0001821586-24-000025.txt   6631941

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20240630.xsd EX-101.SCH 45928
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnlk-20240630_cal.xml EX-101.CAL 69139
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnlk-20240630_def.xml EX-101.DEF 277166
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20240630_lab.xml EX-101.LAB 579939
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20240630_pre.xml EX-101.PRE 451806
88 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20240630_htm.xml XML 782388
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 241181520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)